Methylarsonous acid transport by aquaglyceroporins

Environmental Health Perspectives

Volumn 114, Issue 4, 2006, Pages 527-531

  Liu, Zijuan ^a   Styblo, Miroslav ^b   Rosen, Barry P ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of North Carolina   (United States)

Author keywords

AQP9; Aquaglyceroporin; Arsenic trioxide; Methylarsonous acid

Indexed keywords

AQUAGLYCEROPORIN; ARGININE; ARSENIC ACID; ARSENIC TRIOXIDE; DNA; ESCHERICHIA COLI PROTEIN; INORGANIC ACID; PHENYLALANINE; SACCHAROMYCES CEREVISIAE PROTEIN;

ARTICLE; BACTERIAL STRAIN; CELL MEMBRANE; CONTROLLED STUDY; DNA SEQUENCE; ESCHERICHIA COLI; HUMAN; METHYLATION; NONHUMAN; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; SACCHAROMYCES CEREVISIAE; SITE DIRECTED MUTAGENESIS; TRANSPORT KINETICS;

ANIMALS; AQUAGLYCEROPORINS; ARSENICALS; BASE SEQUENCE; DNA PRIMERS; ESCHERICHIA COLI; RATS; SACCHAROMYCES CEREVISIAE;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MAMMALIA; SACCHAROMYCES CEREVISIAE;

EID: 33645633948     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.8600     Document Type: Article

References (42)

1. Abedin MJ, Cresser MS, Meharg AA, Feldmann J, Cotter-Howells J. 2002. Arsenic accumulation and metabolism in rice ( Oryza sativa L.). Environ Sci Technol 36(5):962-968.
2. Abernathy CO, Liu YP, Longfellow D, Aposhian HV, Beck B, Fowler B, et al. 1999. Arsenic: health effects, mechanisms of actions, and research issues. Environ Health Perspect 107:593-597.
3. Adams A, Gottschling DE, Kaiser C, Stearns T. 1998. Methods in Yeast Genetics: A Cold Spring Harbor Laboratory Course Manual. Cold Spring Harbor, NY:Cold Spring Harbor Laboratory Press.
4. Agre P, Kozono D. 2003. Aquaporin water channels: molecular mechanisms for human diseases. FEBS Lett 555(1):72-78.
5. Borgnia M, Nielsen S, Engel A, Agre P. 1999. Cellular and molecular biology of the aquaporin water channels. Annu Rev Biochem 68:425-458.
6. Carbrey JM, Gorelick-Feldman DA, Kozono D, Praetorius J, Nielsen S, Agre P. 2003. Aquaglyceroporin AQP9: solute permeation and metabolic control of expression in liver. Proc Natl Acad Sci USA 100(5):2945-2950.
7. Carlin A, Shi W, Dey S, Rosen BP. 1995. The arsoperon of Escherichia coliconfers arsenical and antimonial resistance. J Bacteriol 177(4):981-986.
8. Cole SP, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson GM, et al. 1994. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 54(22): 5902-5910.
9. Cullen WR, McBride BC, Pickett AW, Reglinski J. 1984. The wood preservative chromated copper arsenate is a substrate for trimethylarsine biosynthesis. Appl Environ Microbiol 47(2): 443-444.
10. de Groot BL, Grubmuller H. 2001. Water permeation across biological membranes: mechanism and dynamics of aquaporin-1 and GlpF. Science 294(5550):2353-2357.
11. Dopp E, Hartmann LM, Florea AM, von Recklinghausen U, Pieper R, Shokouhi B, et al. 2004. Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells. Toxicol Appl Pharmacol 201(2):156-165.
12. Drobna Z, Jaspers I, Thomas DJ, Styblo M. 2003. Differential activation of AP-1 in human bladder epithelial cells by inorganic and methylated arsenicals. FASEB J 17(1):67-69.
13. Drobna Z, Waters SB, Devesa V, Harmon AW, Thomas DJ, Styblo M. 2005. Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+3 oxidation state)-methyltransferase. Toxicol Appl Pharmacol 207(2):147-159.
14. Fu D, Libson A, Miercke LJ, Weitzman C, Nollert P, Krucinski J, et al. 2000. Structure of a glycerol-conducting channel and the basis for its selectivity. Science 290(5491):481-486.
15. Ghosh M, Shen J, Rosen BP. 1999. Pathways of As(III) detoxification in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 96:5001-5006.
16. Healy SM, Casarez EA, Ayala-Fierro F, Aposhian H. 1998. Enzymatic methylation of arsenic compounds. V. Arsenite methyltransferase activity in tissues of mice. Toxicol Appl Pharmacol 148(1):65-70.
17. Hughes MF, Kenyon EM, Edwards BC, Mitchell CT, Razo LM, Thomas DJ. 2003. Accumulation and metabolism of arsenic in mice after repeated oral administration of arsenate. Toxicol Appl Pharmacol 191(3):202-210.
18. Jensen MO, Tajkhorshid E, Schulten K. 2003. Electrostatic tuning of permeation and selectivity in aquaporin water channels. Biophys J 85(5):2884-2899.
19. Kala SV, Neely MW, Kala G, Prater CI, Atwood DW, Rice JS, et al. 2000. The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic. J Biol Chem 275(43):33404-33408.
20. Kenyon EM, Del Razo LM, Hughes MF. 2005. Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in mice following acute oral administration of arsenate. Toxicol Sci 85(1):468-475.
21. Lee JK, Khademi S, Harries W, Savage D, Miercke L, Stroud RM. 2004. Water and glycerol permeation through the glycerol channel GlpF and the aquaporin family. J Synchrotron Radiat 11(pt 1):86-88.
22. Lin S, Shi Q, Nix FB, Styblo M, Beck MA, Herbin-Davis KM, et al. 2002. A novel S-adenosyl-L-methionine:arsenic(III) methyltransferase from rat liver cytosol. J Biol Chem 277(13): 10795-10803.
23. Liu J, Chen H, Miller DS, Saavedra JE, Keefer LK, Johnson DR, et al. 2001. Overexpression of glutathione S-transferase II and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic. Mol Pharmacol 60(2):302-309.
24. Liu Z, Carbrey JM, Agre P, Rosen BP. 2004. Arsenic trioxide uptake by human and rat aquaglyceroporins. Biochem Biophys Res Commun 316(4):1178-1185.
25. Liu Z, Shen J, Carbrey JM, Mukhopadhyay R, Agre P, Rosen BP. 2002. Arsenite transport by mammalian aquaglyceroporins AQP7 and AQP9. Proc Natl Acad Sci USA 99(9):6053-6058.
26. Meng YL, Liu Z, Rosen BP. 2004. As(III) and Sb(III) uptake by GlpF and efflux by ArsB in Escherichia coli. J Biol Chem 279: 18334-18341.
27. Nollert P, Harries WE, Fu D, Miercke LJ, Stroud RM. 2001. Atomic structure of a glycerol channel and implications for substrate permeation in aqua(glycero)porins. FEBS Lett 504(3): 112-117.
28. Petrick JS, Jagadish B, Mash EA, Aposhian HV. 2001. Monomethylarsonous acid (MMA(III)) and arsenite: LD(50) in hamsters and in vitroinhibition of pyruvate dehydrogenase. Chem Res Toxicol 14(6):651-656.
29. Ramirez-Solis A, Mukopadhyay R, Rosen BP, Stemmler TL. 2004. Experimental and theoretical characterization of arsenite in water: insights into the coordination environment of As-O. Inorg Chem 43(9):2954-2959.
30. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular Cloning, a Laboratory Manual. Cold Spring Harbor, NY:Cold Spring Harbor Laboratory Press.
31. Sanders OI, Rensing C, Kuroda M, Mitra B, Rosen BP. 1997. Antimonite is accumulated by the glycerol facilitator GlpF in Escherichia coli. J Bacteriol 179(10):3365-3367.
32. Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ, et al. 1998. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 339(19):1341-1348.
33. Sui H, Han BG, Lee JK, Walian P, Jap BK. 2001. Structural basis of water-specific transport through the AQP1 water channel. Nature 414(6866):872-878.
34. Tajkhorshid E, Nollert P, Jensen MO, Miercke LJ, O'Connell J, Stroud RM, et al. 2002. Control of the selectivity of the aquaporin water channel family by global orientational tuning. Science 296(5567):525-530.
35. Thomas DJ, Styblo M, Lin S. 2001. The cellular metabolism and systemic toxicity of arsenic. Toxicol Appl Pharmacol 176(2):127-144.
36. Vahter M. 2002. Mechanisms of arsenic biotransformation. Toxicology 181-182:211-217.
37. Walton FS, Harmon AW, Paul DS, Drobna Z, Patel YM, Styblo M. 2004. Inhibition of insulin-dependent glucose uptake by trivalent arsenicals: possible mechanism of arsenic-induced diabetes. Toxicol Appl Pharmacol 198(3):424-433.
38. Walton FS, Waters SB, Jolley SL, LeCluyse EL, Thomas DJ, Styblo M. 2003. Selenium compounds modulate the activity of recombinant rat AsIII-methyltransferase and the methylation of arsenite by rat and human hepatocytes. Chem Res Toxicol 16(3):261-265.
39. Waters SB, Devesa V, Del Razo LM, Styblo M, Thomas DJ. 2004a. Endogenous reductants support the catalytic function of recombinant rat cyt19, an arsenic methyltransferase. Chem Res Toxicol 17(3):404-409.
40. Waters SB, Devesa V, Fricke MW, Creed JT, Styblo M, Thomas DJ. 2004b. Glutathione modulates recombinant rat arsenic (+3 oxidation state) methyltransferase-catalyzed formation of trimethylarsine oxide and trimethylarsine. Chem Res Toxicol 17(12):1621-1629.
41. Wysocki R, Chery CC, Wawrzycka D, Van Hulle M, Cornelis R, Thevelein JM, et al. 2001. The glycerol channel Fps1p mediates the uptake of arsenite and antimonite in Saccharomyces cerevisiae. Mol Microbiol 40(6):1391-1401.
42. Yang HC, Cheng J, Finan TM, Rosen BP, Bhattacharjee H. 2005. Novel pathway for arsenic detoxification in the legume symbiont Sinorhizobium meliloti. J Bacteriol 187(20):6991-6997.